🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this 2-year study is to assess the sustained clinical effica...
Status
Completed
Location
Alergologicka ordinace
Start Date
2010-11
Trial ID
NCT01731249
Treatments Being Tested
This study will assess efficacy and safety of intraseasonal specific short-...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01902992
Treatments Being Tested
Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-07
Trial ID
NCT00266526
Treatments Being Tested
IgE-associated allergies are consistently on the rise forming an enormous w...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2021-11-11
Trial ID
NCT05042830
A Phase III study to determine the sensitivity and specificity of three sol...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01964768
Treatments Being Tested
This trial is performed to assess the tolerability of the ALK Tree Tablet i...
Status
Completed
Location
PhaseOne Trials
Start Date
2007-10
Trial ID
NCT00535639
Treatments Being Tested
Specific immunotherapy for subcutaneous application: Dose finding study to ...
Status
Completed
Location
Dermatology Weber
Start Date
2010-06
Trial ID
NCT01144429
Treatments Being Tested
This trial is performed to assess safety of a sublingual birch pollen extra...
Status
Completed
Location
Prof. Dr. Nicolas Hunzelmann
Start Date
2008-06
Trial ID
NCT00818181
Treatments Being Tested
The main objective is to evaluate the concentration of allergen extract of ...
Status
Completed
Location
Hospital Lucus Augusti
Start Date
2015-09
Trial ID
NCT02527187
The trial is a phase II, randomised, parallel-group, double-blind, placebo-...
Status
Completed
Location
Inflamax Research Inc.
Start Date
2015-06
Trial ID
NCT02481856
Treatments Being Tested